Aerovance, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aerovance.com
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2011-01-27
- Lead Sponsor
- Aerovance, Inc.
- Target Recruit Count
- 424
- Registration Number
- NCT00801853
- Locations
- 🇵🇱
Alergomed Specjalistyczna Przychodnia Lekarska sp zoo, Tarnów, Poland
🇺🇸Asthma and Allergy Research of New Jersey Inc., Philadelphia, Pennsylvania, United States
🇺🇸Allergy and Clinical Immunology, Bangor, Maine, United States
A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
Phase 1
Completed
- Conditions
- Asthma
- First Posted Date
- 2008-11-05
- Last Posted Date
- 2008-11-05
- Lead Sponsor
- Aerovance, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00785668
- Locations
- 🇬🇧
Guy's Drug Research Unit a division of Quintiles Ltd., London, England, United Kingdom
A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
Phase 2
Completed
- Conditions
- Atopic Eczema
- Interventions
- Drug: placeboDrug: Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2008-05-13
- Lead Sponsor
- Aerovance, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00676884
- Locations
- 🇬🇧
Guy's Drug Research unit, Quintiles Limited, London, United Kingdom
Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2007-09-26
- Lead Sponsor
- Aerovance, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00535431
- Locations
- 🇬🇧
Guy's Drug Research Unit, Quintiles, Ltd., London, United Kingdom
A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2007-09-26
- Lead Sponsor
- Aerovance, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00535028
- Locations
- 🇬🇧
Guy's Drug Research Unit, Quintiles, Ltd., 6 Newcomen Street London, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath